BIO vs NPKI · rev $651.0M vs P/E 36, rev $156.7M
BIO (BIO) versus NPK International Inc. (NPKI) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
NPK International Inc. (NPKI) is a building products & equipment company listed on NYSE.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported NPKI revenue for 2026-06-30 was $156.7M. Net income was $22.4M. NPKI currently screens at market cap $1.28B and trailing P/E 36.2.
BIO currently screens at market cap $0. NPKI currently screens at market cap $1.28B and trailing P/E 36.2.
Not investment advice. Open the BIO and NPKI stock pages for the full models.
Not investment advice.